Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,047,908,917
+$157,526,440 QoQ
Shares Held
4,126,113
+13.3% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#64
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $5,124,714,999 across 15 Drug Manufacturers - General names. JNJ ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,697,061 | $2,035,506,044 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
4,126,113 | $1,047,908,917 | |
| 3 | AZN |
Astrazeneca PLC
|
2,746,590 | $520,808,395 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,533,955 | $454,113,217 | |
| 5 | ABBV |
AbbVie Inc.
|
1,279,175 | $321,891,596 | |
| 6 | PFE |
Pfizer Inc
|
10,281,652 | $247,582,179 | |
| 7 | AMGN |
Amgen Inc
|
646,798 | $234,218,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,361,825 | $172,052,970 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,047,908,917 | 4,126,113 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $890,382,477 | 3,642,540 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $752,240,691 | 3,634,891 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $753,317,885 | 4,062,765 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $625,536,606 | 4,095,166 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $784,479,585 | 4,730,340 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $788,335,189 | 5,451,080 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $917,558,114 | 5,661,842 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $789,745,011 | 5,403,291 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $949,687,336 | 6,003,460 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $1,038,339,960 | 6,624,601 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $1,182,525,333 | 7,592,458 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,432,182,986 | 8,652,628 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,166,848,215 | 7,528,053 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,041,456,855 | 5,895,595 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $868,033,452 | 5,313,623 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $1,021,597,918 | 5,755,157 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $849,469,061 | 4,793,032 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $740,147,356 | 4,326,576 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $642,239,633 | 3,976,716 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $765,808,551 | 4,648,589 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $596,750,247 | 3,630,972 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $678,588,250 | 4,311,782 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $681,968,660 | 4,580,660 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $677,720,017 | 4,819,171 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $642,022,052 | 4,896,073 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||